サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768559

免疫沈降の世界市場

Immunoprecipitation

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
免疫沈降の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

免疫沈降の世界市場は2030年までに10億米ドルに達する見込み

2024年に7億1,600万米ドルと推定される免疫沈降の世界市場は、2024年から2030年にかけてCAGR 5.8%で成長し、2030年には10億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬は、CAGR 5.9％を記録し、分析期間終了時には4億5,790万米ドルに達すると予測されています。キットセグメントの成長率は、分析期間中CAGR 6.5％と推定されます。

米国市場は推定1億8,610万米ドル、中国はCAGR9.0％で成長予測

米国の免疫沈降市場は、2024年には1億8,610万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.0%で推移し、2030年には2億3,250万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5%と4.6%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界の免疫沈降市場- 主要動向と促進要因のまとめ

分子生物学調査に免疫沈降が不可欠な理由とは？

免疫沈降（IP）は、分子生物学および生化学において、複雑な生物学的サンプルから特定のタンパク質を分離して研究するために使用される重要な技術です。目的のタンパク質に特異的に結合する抗体を使用することで、研究者はタンパク質を「プルダウン」し、さらなる研究のために分析することができます。免疫沈降は、タンパク質間相互作用、翻訳後修飾、シグナル伝達経路の研究に広く使用されており、がん研究、医薬品開発、基礎生物学研究において非常に貴重なツールとなっています。タンパク質を本来の状態で調査する手段を提供することで、免疫沈降は細胞機能や疾患メカニズムに関する洞察を提供し、研究者が潜在的な治療標的を特定し、疾患の進行をよりよく理解するのに役立ちます。

技術革新はどのように免疫沈降市場を形成しているか？

抗体、試薬、検出方法における技術の進歩は、免疫沈降技術の精度、効率、信頼性を高めています。高親和性モノクローナル抗体やリコンビナント抗体の開発により、IPアッセイの特異性と再現性が大幅に改善され、研究者はより高い精度でタンパク質をターゲットにできるようになりました。さらに、磁気ビーズと架橋試薬の進歩により、免疫沈降のプロセスが簡素化され、バックグラウンドノイズが減少し、標的タンパク質の収量が向上しました。また、質量分析と免疫沈降（IP-MS）の統合は、タンパク質の同定と定量を同時に可能にし、タンパク質複合体やシグナル伝達ネットワークに関するより深い洞察を提供することで、この分野に革命をもたらしました。このような技術革新により、プロテオミクス、創薬、バイオマーカー研究における免疫沈降の応用が広がっています。

市場セグメンテーションは免疫沈降産業の成長をどのように規定するか？

免疫沈降の種類には、クロマチン免疫沈降（ChIP）、co-免疫沈降（Co-IP）、RNA免疫沈降（RIP）があり、co-免疫沈降はタンパク質間相互作用を研究できるため、最も広く使用されています。免疫沈降のアプリケーションは、創薬、プロテオミクス研究、疾病診断に及び、プロテオミクス研究は、疾病メカニズムの理解におけるタンパク質相互作用研究の需要の高まりにより、最大の市場シェアを占めています。エンドユーザーには、学術研究機関、製薬会社、CRO（医薬品開発業務受託機関）などが含まれ、製薬会社は創薬・研究開発プロセスにおいてIPの利用を増やしており、需要を牽引しています。

免疫沈降市場の成長を促進する要因は？

免疫沈降市場の成長は、プロテオミクス調査需要の高まり、抗体技術の進歩、創薬やバイオマーカー同定への注目の高まりなど、いくつかの要因によってもたらされます。研究者がタンパク質の相互作用や疾患における役割を理解することに注力するにつれ、信頼性の高い免疫沈降技術への需要が高まっています。より特異的な抗体や改良された試薬の開発などの技術の進歩により、IPはより身近で効率的なものとなっています。質量分析計やその他の高度な検出方法の統合も、複雑なタンパク質ネットワークの研究能力を高め、学術研究や製薬研究におけるIPの採用を促進しています。さらに、がん研究や個別化医療におけるIPの利用の増加が市場の拡大に寄与しています。

セグメント

コンポーネント（試薬、キット、付属品）;エンドユース（学術・研究機関、製薬・バイオファーマ企業、契約研究機関）

調査対象企業の例

  • Abbkine Scientific Co. Ltd.
  • Abcam PLC
  • BioLegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology Inc.
  • Geno Technology Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22017

Global Immunoprecipitation Market to Reach US$1.0 Billion by 2030

The global market for Immunoprecipitation estimated at US$716.0 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$457.9 Million by the end of the analysis period. Growth in the Kits segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$186.1 Million While China is Forecast to Grow at 9.0% CAGR

The Immunoprecipitation market in the U.S. is estimated at US$186.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$232.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Immunoprecipitation Market - Key Trends and Drivers Summarized

Why Is Immunoprecipitation Essential in Molecular Biology Research?

Immunoprecipitation (IP) is a critical technique used in molecular biology and biochemistry to isolate and study specific proteins from complex biological samples. It involves using an antibody that specifically binds to the protein of interest, allowing researchers to “pull down” the protein and analyze it for further study. Immunoprecipitation is widely used for studying protein-protein interactions, post-translational modifications, and signaling pathways, making it an invaluable tool in cancer research, drug development, and basic biological research. By providing a means to study proteins in their native state, immunoprecipitation offers insights into cellular functions and disease mechanisms, helping researchers identify potential therapeutic targets and better understand disease progression.

How Are Technological Innovations Shaping the Immunoprecipitation Market?

Technological advancements in antibodies, reagents, and detection methods are enhancing the precision, efficiency, and reliability of immunoprecipitation techniques. The development of high-affinity monoclonal antibodies and recombinant antibodies has significantly improved the specificity and reproducibility of IP assays, allowing researchers to target proteins with greater accuracy. Additionally, advancements in magnetic beads and cross-linking reagents have simplified the immunoprecipitation process, reducing background noise and improving the yield of target proteins. The integration of mass spectrometry with immunoprecipitation (IP-MS) has also revolutionized the field by enabling the simultaneous identification and quantification of proteins, providing deeper insights into protein complexes and signaling networks. These innovations are expanding the applications of immunoprecipitation in proteomics, drug discovery, and biomarker research.

How Do Market Segments Define the Growth of the Immunoprecipitation Industry?

Types of immunoprecipitation include chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Co-IP), and RNA immunoprecipitation (RIP), with co-immunoprecipitation being the most widely used due to its ability to study protein-protein interactions. Applications of immunoprecipitation span across drug discovery, proteomics research, and disease diagnostics, with proteomics research holding the largest market share due to the growing demand for protein interaction studies in understanding disease mechanisms. End-users include academic research institutes, pharmaceutical companies, and contract research organizations (CROs), with pharmaceutical companies driving demand as they increasingly use IP in drug discovery and development processes.

What Factors Are Driving the Growth in the Immunoprecipitation Market?

The growth in the immunoprecipitation market is driven by several factors, including the rising demand for proteomics research, advancements in antibody technologies, and the growing focus on drug discovery and biomarker identification. As researchers focus on understanding protein interactions and their role in disease, the demand for reliable immunoprecipitation techniques is increasing. Technological advancements, such as the development of more specific antibodies and improved reagents, are making IP more accessible and efficient. The integration of mass spectrometry and other advanced detection methods is also enhancing the ability to study complex protein networks, driving the adoption of IP in academic and pharmaceutical research. Furthermore, the increasing use of IP in cancer research and personalized medicine is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Immunoprecipitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents, Kits, Accessories); End-Use (Academic & Research Institutes, Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbkine Scientific Co. Ltd.
  • Abcam PLC
  • BioLegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology Inc.
  • Geno Technology Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Immunoprecipitation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Immunoprecipitation in Protein Purification and Analysis Expands Market Opportunities
    • Rising Demand for Immunoprecipitation in Biomedical and Clinical Research Drives Market Growth
    • Technological Advancements in Immunoprecipitation Kits and Reagents Strengthen Product Innovation
    • Increasing Focus on Precision Medicine and Personalized Therapies Fuels Demand for Immunoprecipitation Techniques
    • Rising Adoption of Immunoprecipitation in Epigenetics and Chromatin Studies Boosts Market Demand
    • Expansion of Immunoprecipitation Applications in Cancer Research and Proteomics Propels Market Growth
    • Growing Use of Immunoprecipitation in Drug Discovery and Development Strengthens the Business Case
    • Technological Innovations in Magnetic Bead-Based Immunoprecipitation Drives Product Differentiation
    • Rising Focus on Targeted Protein Interaction Studies Expands the Scope of Immunoprecipitation Techniques
    • Growing Interest in Immunoprecipitation for Post-Translational Modification Studies Spurs Demand
    • Expansion of Immunoprecipitation in Stem Cell Research and Regenerative Medicine Creates New Opportunities
    • Increasing Automation and High-Throughput Capabilities in Immunoprecipitation Strengthen Market Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunoprecipitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Immunoprecipitation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • CHINA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Immunoprecipitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Immunoprecipitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • INDIA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Immunoprecipitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Immunoprecipitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • AFRICA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030

IV. COMPETITION